Onco-Nephrology: Managing Kidney Health in Cancer Patients
Special Issue Information
Dear Colleagues,
Cancer survival continues to improve owing to advances in both conventional and targeted therapies. However, patients with cancer and kidney involvement remain a particularly vulnerable population, with higher morbidity and mortality to those without kidney problems. Moreover, many survivors continue to face challenges related to cancer-associated chronic kidney disease (CKD), which can significantly impair daily functioning and overall health.
Onconephrology has thus emerged as a critical field at the intersection of oncology and nephrology. This Special Issue seeks to highlight key areas, including acute kidney injury (AKI) related to chemotherapy and targeted therapies, with an emphasis on novel biomarkers; nephrotoxic stewardship strategies to prevent AKI; the management of patients with cancer and pre-existing kidney disease, including the unique challenges of kidney transplant recipients; and the long-term risk of CKD in cancer survivors, along with programs to support kidney health.
This Special Issue of Cancers aims to bring together innovative research, insightful reviews, and practical strategies in the rapidly evolving field of onconephrology. It seeks to support more individualized clinical decision-making and to advance the development of tailored care pathways for this complex patient population.
Dr. Gerrit van den Berg
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- onconephrology
- nephrotoxicity
- acute kidney injury
- chronic kidney disease
- kidney health
- nephrotoxin stewardship
- cancer survival
- personalized medicine
- supportive care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

